Major Pharmaceutical Markets of the Middle East

Chapter 1: Characteristics of the Middle Eastern Pharmaceutical Market

Political, economic, social and technological (PEST) analysis
Political factors
Economic factors
Social factors
Technological factors
Free trade agreements
Euro-Mediterranean Free Trade Area (EU-MEFTA)
US-MEFTA (Middle East Free Trade Agreements)
Gulf Cooperation Council (GCC)
Taxation
Egypt
Israel
Jordan
Lebanon
Saudi Arabia
United Arab Emirates

Chapter 2: Intellectual Property Rights

Trade-related Aspects of Intellectual Property Rights (TRIPS)
Egypt
Israel
Jordan
Lebanon
Saudi Arabia
United Arab Emirates

Chapter 3: Overview of the Middle Eastern Pharmaceutical Market

Healthcare overview
Pharmaceutical consumption
Domestic production
Imports
Market forecast

Chapter 4: Egypt

The healthcare structure
The pharmaceutical market
Market figures
Drug pricing and reimbursement
Distribution
Cost controls
Public tenders
Patient co-payment
Generic substitution
Leading companies

Chapter 5: Israel

The healthcare structure
The pharmaceutical market
Market figures
Drug pricing and reimbursement
Distribution
Cost controls
Prescribing limitations
Generic substitution
Patient co-payment
Leading companies

Chapter 6: Jordan

The healthcare structure
The pharmaceutical market
Market figures
Point of interest: medical tourism
Drug pricing and reimbursement
Distributio
Cost controls
Co-payment
Public-sector procurement
Leading companies

Chapter 7: Lebanon

The healthcare structure
Point of interest: fraud
The pharmaceutical market
Market figures
Drug pricing and reimbursement
Distribution
Cost controls
Public procurement
National Drugs Office
Patient co-payment
Leading companies

Chapter 8: Saudi Arabia

The healthcare structure
Pharmaceutical market
Market figures
Drug pricing and reimbursement
Distribution
Cost controls
Private health insurance provision
'Dollarisation'
Gulf Cooperation Council bulk buying
Leading companies

Chapter 9: United Arab Emirates

The healthcare structure
Pharmaceutical market
Market figures
Drug pricing and reimbursement
Distribution
Cost controls
Bulk buying
Co-payment
Leading companies

Appendix

Abbreviations
Useful contacts
Egypt
Israel
Jordan
Lebanon
Saudi Arabia
United Arab Emirates
Selected bibliography

List of Figures

Figure 3.1 Projected market sizes for Egypt, Saudi Arabia and Israel
Figure 3.2 Projected market sizes for the UAE, Lebanon and Jordan
Figure 4.1 Exchange rate fluctuations (Egyptian pounds to the US dollar), 1997-2005
Figure 5.1 Drug purchasers by share, 2001
Figure 6.1 Jordan's sources of healthcare funds
Figure 6.2 Jordan's national health expenditure, by healthcare provider
Figure 7.1 Institutional framework of Lebanon's pharmaceutical sector
Figure 9.1 Purchasers of pharmaceuticals in the public sector

List of Tables

Table 1.1 Regional PEST factors affecting the pharmaceutical industry in the Middle East
Table 2.1 Estimates of intellectual property losses inflicted on PhRMA members, 2004
Table 3.1 Health indicators, 2003
Table 3.2 Pharmaceutical market sizes in the Middle East, 2003
Table 3.3 Annual per capita drug consumption figures in the Middle East, 2001
Table 3.4 Largest local pharmaceutical manufacturers in the Middle East 1
Table 3.5 Competitiveness of Middle Eastern pharmaceutical markets
Table 3.6 Pharmaceutical imports and exports in the Middle East, 2003
Table 4.1 Egypt's healthcare spending
Table 4.2 Egypt's health and government budgets
Table 4.3 Consumer expenditure on health goods and medical services (LEm)
Table 4.4 OTC sales (LEm)
Table 4.5 Egypt's average annual patient co-payment (Egyptian pounds)
Table 4.6 Egypt's top 10 pharmaceutical companies, by revenue, 2001
Table 4.7 Egypt's top 10 pharmaceutical products, by revenue, 2001
Table 4.8 PEST factors affecting Egypt's pharmaceutical industry
Table 5.1 Israel's healthcare expenditure
Table 5.2 Israel's pharmaceutical market, at retail prices
Table 5.3 Israel's consumer expenditure on health goods and medical services
Table 5.4 Israel's pharmaceutical exports and imports
Table 5.5 Israel's non-prescription pharmaceutical market, at retail prices
Table 5.6 Retail sales of OTC healthcare in Israel
Table 5.7 Co-payments for medicines by sick fund in Israel
Table 5.8 Teva's sales and net income
Table 5.9 PEST factors affecting Israel's pharmaceutical industry
Table 6.1 Jordan's health insurance coverage
Table 6.2 Breakdown of Jordan's public health spending
Table 6.3 Jordan's Ministry of Health budgets, 2000-04 (JDm)
Table 6.4 Jordan's health insurance budget, 2000-02 (JDm)
Table 6.5 Admission costs for Jordan's public hospitals
Table 6.6 Dar Al Dawa financials
Table 6.7 PEST factors affecting Jordan's pharmaceutical industry
Table 7.1 Lebanon's pharmaceutical market size and imports
Table 7.2 Co-payments by insurer, in Lebanon
Table 7.3 Hospital co-payments by insurer, in Lebanon
Table 7.4 Lebanon's pharmaceutical production and exports
Table 7.5 PEST factors affecting Lebanon's pharmaceutical industry
Table 8.1 Saudi health-sector statistics, 2003
Table 8.2 Saudi healthcare spending
Table 8.3 Saudi consumer expenditure on health goods and services
Table 8.4 The Saudi private pharmaceutical market
Table 8.5 Saudi pharmaceutical imports (SRm)
Table 8.6 Saudi retail sales of OTC healthcare
Table 8.7 SPIMACO sales and profits, 2003 and 2004
Table 8.8 Tabuk's turnover
Table 8.9 Market share estimates for the Saudi private market, 2005
Table 8.10 Sales estimates for leading products in the Saudi private market, 2005
Table 8.11 Estimates of leading products by units in the Saudi private market, 2005
Table 8.12 PEST factors affecting the Saudi pharmaceutical industry
Table 9.1 Dubai's trade in pharmaceutical products
Table 9.2 Revenue of Drug Control Department by category (in AED)
Table 9.3 Julphar sales and profits
Table 9.4 PEST factors affecting the pharmaceutical industry in the UAE